TVARDI THERAPEUTICS, INC. Stock Split Ratio
TVARDI THERAPEUTICS, INC. (TVRD) had Stock Split Ratio of 8.30% as of 2024-12-19, per its 10-Q filed 2025-05-13.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-05-13
- TVARDI THERAPEUTICS, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2014 was 250.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|
| 2024-12-19 | 8.30% 10-Q · filed 2025-05-13 | ||||
| 2014-12-31 | 250.00% 10-K · filed 2015-03-27 | ||||
| 2014-09-30 | 250.00% 10-Q · filed 2014-11-10 | ||||
| 2014-06-30 | 250.00% 10-Q · filed 2014-08-07 | ||||
| 2014-03-31 | 250.00% 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |